Pope Undergoes Lung Cancer Surgery, Highlighting Non-Smoker Risk
Translated & summarized from Ynet by baba
The Pope underwent surgery for lung cancer, a diagnosis that underscores the disease's prevalence among non-smokers. While smoking causes about 80% of lung cancer cases, a significant portion affects those who have never smoked. Experts emphasize the importance of early detection through methods like low-dose CT scans, though routine screening is currently limited to smokers and former smokers. Advanced treatments like targeted therapy and immunotherapy are improving outcomes for patients.
The story in 6 lines · by baba
- The Pope underwent surgery for adenocarcinoma, the most common type of lung cancer.
- Approximately one-fifth of lung cancer cases occur in individuals who have never smoked.
- Lung cancer is the leading cause of cancer-related death globally.
- Early detection via low-dose chest CT scans is crucial for reducing mortality.
- Routine lung cancer screening is currently recommended only for smokers and former smokers.
- New treatments like targeted therapy and immunotherapy are improving patient survival rates.
The Pope underwent surgery at Gemelli Hospital in Rome, where the lower lobe of his right lung was removed. Pathology confirmed adenocarcinoma, the most common type of lung cancer. The 71-year-old pontiff is not known to be a smoker, a fact that highlights that lung cancer can affect non-smokers. Dr. Mea Gottfried, director of oncology at Meir Medical Center, stated that while about 80% of lung cancer cases are linked to smoking, approximately one-fifth occur in individuals who have never smoked.
Lung cancer is the leading cause of cancer death worldwide. In 2022, the World Health Organization reported approximately 2.5 million new cases and 1.8 million deaths. Risk factors beyond smoking include exposure to secondhand smoke, radon gas, air pollution, and occupational carcinogens like asbestos and diesel fumes. Certain lung diseases and family history can also play a role, with the disease being more common in older individuals.
Dr. Gottfried explained that non-small cell lung cancer, including adenocarcinoma diagnosed in the Pope, accounts for about 85% of cases, while small cell lung cancer makes up 10-15%. The distinction is crucial as it affects prognosis and treatment. Small cell lung cancer has a particularly strong link to smoking, with about 97% of patients being smokers, whereas adenocarcinoma can occur in both smokers and non-smokers.
Early detection is key to reducing mortality. A low-dose chest CT scan is the primary tool for early detection and is included in Israel's national health basket for smokers and former smokers aged 60-74 who meet specific criteria. However, there is currently no routine screening recommendation for never-smokers, as the benefits may not outweigh the potential harms. For these individuals, the disease is typically discovered due to symptoms or incidentally.
Symptoms can include persistent cough, shortness of breath, chest or rib pain, shoulder pain, general weakness, hoarseness, unexplained weight loss, appetite loss, and recurrent lung infections. New or worsening symptoms warrant a doctor's visit, even for non-smokers. The article also details the diagnostic process, including biopsies and imaging like PET-CT and MRI, and discusses modern treatment options such as targeted therapy and immunotherapy, which have significantly expanded treatment possibilities and improved survival rates.